Characterizing a Clinical Trial - Representative, Real-World Population with Heart Failure with Reduced Ejection Fraction

被引：1

作者：

Wells, Quinn S. ^{[1
,2
]}

Farber-Eger, Eric ^{[1
,2
]}

Lipworth, Loren ^{[2
,3
]}

Dluzniewski, Paul ^{[4
]}

Dent, Ricardo ^{[4
]}

Umeijiego, John ^{[4
]}

Cohen, Sarah S. ^{[3
,5
]}

机构：

[1] Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Med Ctr, Nashville, TN USA

[2] Vanderbilt Univ, Med Ctr, Vanderbilt Translat & Clin Cardiovasc Res Ctr VTR, Nashville, TN USA

[3] Vanderbilt Univ, Dept Med, Div Epidemiol, Med Ctr, Nashville, TN 37235 USA

[4] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA

[5] Toxstrategies Inc, Epidstrategies, Cary, NC 27511 USA

来源：

CLINICAL EPIDEMIOLOGY | 2022年 / 14卷

关键词：

heart failure; reduced ejection fraction; real-world evidence; electronic health record; RANDOMIZED INTERVENTION TRIAL; CIBIS-II; MORTALITY; ENALAPRIL; SURVIVAL; METOPROLOL; MORBIDITY; OUTCOMES;

D O I：

10.2147/CLEP.S341919

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

li li li Conclusion: Approximately 40% of RW HFrEF patients met criteria for the GALACTICHF trial. While findings of ongoing clinical trials may be directly generalizable to this sizable proportion of patients, future trials should examine whether the majority of patients with lower prevalence of comorbidities and rate of HF hospitalization could benefit from emerging HF treatments.

引用

页码：39 / 49

页数：11

共 50 条

[31] Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry
Zeymer, Uwe
Clark, Andrew L.
Barrios, Vivencio
Damy, Thibaud
Drozdz, Jaroslaw
Fonseca, Candisda
Lund, Lars H.
Kalus, Stefanie
Ferber, Philippe C.
Hussain, Rizwan, I
Koch, Cornelia
Maggioni, Aldo P.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (04) : 469 - 477
[32] Real-World Analysis of Diuretic Requirements in Patients with Heart Failure with Reduced Ejection Fraction after Initiation of Sacubitril/Valsartan
Miah, A.
Ahmed, U.
Pirlamarla, P.
Reeves, G.
Abbas, C.
Shah, M.
Alvarez, R.
Cozzi, S.
Demastus, C.
Ervin, A.
Danelich, I.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S152 - S153
[33] Multicentre experience of intravenous ferric carboxymaltose in heart failure with reduced ejection fraction: real-world effect on quality of life
Jeyalan, V. Visvesh
Richardson, K.
Mcneill, H.
Hardy, L.
Crouchley, J.
Mukhopadhyay, I.
Hann, K.
Hunt, T.
Baker, A.
Thambyrajah, J.
Dewhurst, M.
Clark, A.
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 319 - 319
[34] Sacubitril/Valsartan in the Treatment of Right Ventricular Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction: A Real-world Study
Yang, Ying
Shen, Chao
Lu, Jiangting
Fu, Guosheng
Xiong, Cui
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 177 - 182
[35] Real-World Safety of Sacubitril/Valsartan in Women and Men With Heart Failure and Reduced Ejection Fraction: A Meta-analysis
Nuechterlein, Kaitlin
AlTurki, Ahmed
Ni, Jiayi
Martinez-Selles, Manuel
Martens, Pieter
Russo, Vincenzo
Backelin, Charlotte Nordberg
Huynh, Thao
CJC OPEN, 2021, 3 (12) : S202 - S208
[36] INCIDENCE AND PREDICTORS OF DYSKALEMIA IN REAL-WORLD HEART FAILURE PATIENTS WITH PRESERVED, MID-RANGE AND REDUCED EJECTION FRACTION
Savarese, Gianluigi
Xu, Hong
Trevisan, Marco
Dahlstrom, Ulf
Pitt, Bertram
Carrero, Juan Jesus
Carrero, Juan J.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 715 - 715
[37] Use of mineralocorticoid receptor antagonists in a real-world population with heart failure and reduced ejection fraction: an analysis of 24,529 patients from the swedish heart failure registry
Savarese, G.
Carrero, J. J.
Pitt, B.
Anker, S.
Dahlstrom, U.
Lund, L. H.
EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 344 - 344
[38] Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized With Heart Failure and Reduced Ejection Fraction
Fudim, Marat
Sayeed, Sabina
Xu, Haolin
Matsouaka, Roland A.
Heidenreich, Paul A.
Velazquez, Eric J.
Yancy, Clyde W.
Fonarow, Gregg C.
Hernandez, Adrian F.
DeVore, Adam D.
CIRCULATION-HEART FAILURE, 2020, 13 (04)
[39] Baseline characteristics and clinical features of patients with heart failure with reduced ejection fraction: a European real-world, non-interventional registry study
Zeymer, U.
Lunde, L. H.
Barrios, V
Fonseca, C.
Clark, A. L.
Damy, T.
Drozdz, J.
Kalus, S.
Koch, C.
Maggioni, A.
EUROPEAN HEART JOURNAL, 2020, 41 : 1063 - 1063
[40] Effects of sacubitril/valsartan on the functional capacity of real-world patients in Italy: the REAL.IT study on heart failure with reduced ejection fraction
Sarullo, Filippo Maria
Nugara, Cinzia
Sarullo, Silvia
Iacoviello, Massimo
Di Gesaro, Gabriele
Miani, Daniela
Driussi, Mauro
Correale, Michele
Bilato, Claudio
Passantino, Andrea
Carluccio, Erberto
Villani, Alessandra
Degli Esposti, Luca
D'Agostino, Chiara
Peruzzi, Elena
Poli, Simone
Di Lenarda, Andrea
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11

← 1 2 3 4 5 →